Status:
COMPLETED
Campath-1H Induction to Allow Discontinuation of Calcineurin Inhibitors After Renal Transplantation
Lead Sponsor:
University of Wisconsin, Madison
Conditions:
Primary Renal Transplant
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether Campath-1H induction therapy and the associated lymphocyte depletion will permit long-term, rejection free renal allograft function in the absence of ...
Eligibility Criteria
Inclusion
- received a renal transplant, induction with Campath-1H, and at least 2 months of calcineurin inhibitor therapy, CellCept, and prednisone.
Exclusion
- Recipients of HLA-identical living-donor renal transplants;
- PRA value \>20% within 30 days of transplant;
- GFR \<40ml/min;
- multi-organ transplant;
Key Trial Info
Start Date :
May 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2009
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00214201
Start Date
May 1 2003
End Date
May 1 2009
Last Update
October 3 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Wisconsin
Madison, Wisconsin, United States, 53792